mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.17 |
0.3 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.061 |
0.3 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.17 |
0.3 |